Skip to main content
. 2010 May 11;95(7):1098–1105. doi: 10.3324/haematol.2009.017103

Figure 1.

Figure 1.

Flavopiridol pharmacokinetics. Plasma flavopiridol (A) and flavopiridol glucuronide (flavo-G, B) concentration-time profiles through 80 hours for cycle 1 in 23 of 24 patients with evaluable PK profiles (PK data from one patient extends through 150 hours due to dosing delays resulting from toxicity). Flavopiridol glucuronide concentrations were not determined for day 2.